Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition
Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lynn Morris(National Health Laboratory Service), Michal Juraska(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nigel Garrett(Centre for the AIDS Programme of Research in South Africa), Yunda Huang(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Raabya Rossenkhan(Fred Hutch Cancer Center), Haili Tang(Chinese Center For Disease Control and Prevention), Bette Korber(Los Alamos National Laboratory), Ying Huang(Fred Hutch Cancer Center), Myron S. Cohen(University of North Carolina at Chapel Hill), Caroline Brackett(Duke University), Tandile Hermanus(National Health Laboratory Service), James I. Mullins(University of Washington), Elize Domin(Duke University), Paul T. Edlefsen(Fred Hutch Cancer Center), Allan C. deCamp(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Nidhi Kochar(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Craig A. Magaret(Fred Hutch Cancer Center), Nonhlanhla N. Mkhize(Respiratory and Meningeal Pathogens Research Unit), Georgia D. Tomaras(National Institutes of Health), Amanda Eaton(Duke Medical Center), Carolyn Williamson(National Health Laboratory Service), Rutendo E. Mapengo(National Health Laboratory Service), Wenhong Feng(Duke Medical Center), Cynthia L. Gay(University of North Carolina at Chapel Hill), Erika Rudnicki(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Dan H. Barouch(Beth Israel Deaconess Medical Center), Valerie Bekker(National Health Laboratory Service), Joseph Makhema(Norwegian Womens Public Health Association), Lawrence Corey(Fred Hutch Cancer Center), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bryan T. Mayer(Fred Hutch Cancer Center), Jack Heptinstall(Duke University), Kelvin Chiong(Duke University), Prudence Kgagudi(National Health Laboratory Service), Haajira Kaldine(National Health Laboratory Service), Lindsay N. Carpp(Fred Hutch Cancer Center), Elena E. Giorgi(Fred Hutch Cancer Center), Magdalena E. Sobieszczyk(Columbia University Irving Medical Center), P. Andrew(Family Health International 360), Daniel B. Reeves(Fred Hutch Cancer Center), Carley West(Duke Medical Center), Yuanyuan Zhang(Hainan Medical University), Jorge Sánchez(National University of San Marcos), Kelly E. Seaton(International Vaccine Institute), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David C. Montefiori(Duke University)
Cited by 132
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Antiretroviral Therapy for the Prevention of HIV-1 Transmission
|New England Journal of Medicine|2016|1.7k